Certara stock.

PRINCETON, N.J.—September 3, 2021. Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced a proposed underwritten public offering of 20,000,000 shares of its common stock pursuant to a registration statement filed with the Securities and Exchange Commission. Certara is offering 4,500,000 shares of common stock and ...

Certara stock. Things To Know About Certara stock.

Ms Sherman CERT stock SEC Form 4 insiders trading. Ms has made over 1 trades of the Certara stock since 2023, according to the Form 4 filled with the SEC. Most recently she exercised 3,990 units of CERT stock worth $50,194 on 31 March 2023.. The largest trade she's ever made was exercising 3,990 units of Certara stock on 31 March …John Gallagher CERT stock SEC Form 4 insiders trading. John has made over 9 trades of the Certara stock since 2015, according to the Form 4 filled with the SEC. Most recently John exercised 5,746 units of CERT stock worth $437,730 on 27 February 2018.. The largest trade John's ever made was exercising 5,746 units of Certara stock …Certara share price went down by -16.68% last month. The next quarterly earnings date for Certara is scheduled on November 7, 2023. Certara's next ex-dividend date is August 20, 2023.If you want to keep up to date on the stock market you have a device in your pocket that makes that possible. Your phone can track everything finance-related and help keep you up to date on the world markets.Nov 21, 2023 · Certara, Inc. is a provider of biosimulation software and technology-enabled services. The Company is focused on producing medicines for patients using biosimulation software, technology, and services to transform traditional drug discovery and development.

Certara is the leading provider of model-informed drug development technology and services, as well as a best-in-class provider of regulatory science, writing, and submission management software and services. Certara’s solutions help inform the drug development and regulatory approval process and address the key efficacy, safety, …Get Certara alerts: Insider Activity at Certara. In other Certara news, major shareholder Avatar Parent L.P. Eqt sold 1,500,000 shares of the company's stock in a transaction dated Tuesday, May 31st. The stock was sold at an average price of $19.00, for a total value of $28,500,000.00.November 15, 2021. PRINCETON, N.J.– November 15, 2021– Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced a proposed underwritten public offering by certain selling stockholders of 10 million shares of its common stock pursuant to a registration statement filed with the Securities and Exchange Commission.

Open $0.9454. Day Range 0.9230 - 1.0100. 52 Week Range 0.7078 - 1.6300. Market Cap $454.63M. Shares Outstanding 399.78M. Public Float 370.52M. Beta 1.69. Rev. per Employee $3.692M. P/E Ratio N/A.Mar 14, 2023 · Certara, Inc. (CERT) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? By taking a look at the stock's year ...

Smart Screens. Smart Screens Search stocks using 100s of variables and make your own screensStarting January 1, 2020, all regulatory transactions for Master Files prepared in the non-eCTD format must be sent via the Common Electronic Submission Gateway (CESG). We have seen a spike in these types of submissions. The CESG has been in operation at Health Canada since February 2014, and it provides a secure and prompt …Complete Certara Inc. stock information by Barron's. View real-time CERT stock price and news, along with industry-best analysis.Which Certara insiders have been buying company stock? The following insiders have purchased CERT shares in the last 24 months: Eran Broshy ($3,107.30), Michael Andrew Schemick ($416,000.00), and Stephen M Mclean ($326,400.00).Penny stocks may sound like an interesting investment option, but there are some things that you should consider before deciding whether this is the right investment choice for you.

Arsenal closed the previously announced $449M stock purchase from funds controlled by EQT Private EquityPRINCETON, N.J., Dec. 08, 2022 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT) today ...

In terms of valuation, Certara Inc. stock appears to be trading at a premium compared to its peers in the same industry. The company's market capitalization stands at approximately $3.1 billion ...

Mason Slaine CERT stock SEC Form 4 insiders trading. Mason has made over 9 trades of the Certara stock since 2021, according to the Form 4 filled with the SEC. Most recently Mason sold 250,000 units of CERT stock worth $3,890,000 on 14 November 2022.. The largest trade Mason's ever made was selling 620,668 units of Certara stock …Certara, Inc. is a provider of biosimulation software and technology-enabled services. The Company is focused on producing medicines for patients using biosimulation software, technology, and services to transform traditional drug discovery and development.Oct 11, 2023 · PRINCETON, N.J, Oct. 11, 2023 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that it will release financial results for the third quarter of 2023 after the market close on Wednesday November 8 th , 2023. Commit To Buy Certara At $12.50, Earn 14.4% Annualized Using Options Stock Options Channel Staff - Friday, November 17, 2:05 PM. Investors considering a purchase of Certara Inc stock, but cautious about paying the going market price of $14.65/share, might benefit from considering selling puts among the alternative …Patrick Smith CERT stock SEC Form 4 insiders trading. Patrick has made over 6 trades of the Certara stock since 2022, according to the Form 4 filled with the SEC. Most recently Patrick sold 19,104 units of CERT stock worth $411,691 on 5 June 2023.. The largest trade Patrick's ever made was selling 19,104 units of Certara stock on 5 June …

Mar 17, 2023 · In terms of valuation, Certara Inc. stock appears to be trading at a premium compared to its peers in the same industry. The company's market capitalization stands at approximately $3.1 billion ... Patrick Smith CERT stock SEC Form 4 insiders trading. Patrick has made over 5 trades of the Certara stock since 2022, according to the Form 4 filled with the SEC. Most recently Patrick exercised 8,646 units of CERT stock worth $181,307 on 31 March 2023.8,646 units of CERT stock worth $181,307 on 31 March 2023.Certara stock drops after biotech software company misses profit target. Certara Inc. CERT, -2.56% stock was down 14.6% in premarket trades on Thursday …Third Quarter Highlights: Revenue was $85.6 million, PRINCETON, N.J, Oct. 11, 2023 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that it will release financial results for the third quarter of 2023 after the market close on Wednesday November 8 th , 2023.The average twelve-month price prediction for Palantir Technologies is $13.25 with a high price target of $25.00 and a low price target of $5.00. Learn more on PLTR's analyst rating history. Do Wall Street analysts like Palantir Technologies more than its competitors? Analysts like Palantir Technologies less than other Business Services …PRINCETON, N.J., Sept. 19, 2023 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced it has successfully supported 300 completed submissions to ...

The Nasdaq Stock Market LLC Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing …

See the latest Certara Inc Ordinary Shares stock price (CERT:XNAS), related news, valuation, dividends and more to help you make your investing decisions.Arsenal will acquire approximately 30M shares at $15 per share from funds controlled by EQT Private Equity and agrees to two-year lock-up on sale of shares. PRINCETON, N.J.— November 7, 2022 — Certara, Inc. (Nasdaq: CERT) today announced that Arsenal Capital Partners (“Arsenal”), a private equity firm specializing in investing in and building transformational healthcare companies, has ...ClearBridge Investments highlighted stocks like Certara, Inc. (NASDAQ: CERT) in its Q3 2022 investor letter. Headquartered in Princeton, New Jersey, Certara, Inc. (NASDAQ:CERT) is a software ...Avatar has made over 8 trades of the Certara stock since 2020, according to the Form 4 filled with the SEC. Most recently Avatar sold 29,954,521 units of CERT stock worth $449,317,815 on 8 December 2022.Ms Choe CERT stock SEC Form 4 insiders trading. Ms has made over 7 trades of the Certara stock since 2021, according to the Form 4 filled with the SEC. Most recently she sold 7,500 units of CERT stock worth $210,000 on 20 December 2021.. The largest trade she's ever made was selling 20,000 units of Certara stock on 19 November …With Certara, Inc. shares trading a bit north of 30 times earnings and nearly 6.5 times forward sales, there is nothing compelling about the stock's current valuation given Certara's projected ...Craig Rayner CERT stock SEC Form 4 insiders trading. Craig has made over 2 trades of the Certara stock since 2021, according to the Form 4 filled with the SEC. Most recently Craig sold 54,462 units of CERT stock worth $1,978,604 on 2 September 2021.. The largest trade Craig's ever made was selling 108,924 units of Certara stock on 11 …

Arena Pharmaceuticals. 22-Feb-1999. Later Stage VC. 0000. Completed. 5 buyers. To view Certara’s complete exits history, request access ». Information on stock, financials, earnings, subsidiaries, investors, and executives for Certara. Use the PitchBook Platform to explore the full profile.

Nov 21, 2023 · Certara, Inc. is a provider of biosimulation software and technology-enabled services. The Company is focused on producing medicines for patients using biosimulation software, technology, and services to transform traditional drug discovery and development.

Certara Inc CERT:US Nasdaq GS (USD) Delayed price as of 2:59 PM EST 11/21/23. Market open. 14.45 –0.27 –1.80% Prev. close 14.71 USD 14.45 USD 3:00 PM …PRINCETON, N.J.—September 3, 2021. Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced a proposed underwritten public offering of 20,000,000 shares of its common stock pursuant to a registration statement filed with the Securities and Exchange Commission. Certara is offering 4,500,000 shares of common stock and ...Certara Inc Ordinary Shares 700 Morningstar Rating Unlock Stock XBER Rating as of Nov 17, 2023 Summary Chart News Price vs Fair Value Sustainability Trailing Returns Financials Valuation...Certara is listed on the Nasdaq stock exchange under the ticker symbol “CERT.” When did Certara go public, and what was the offering price? Certara’s initial public offering was on December 11, 2020 at $23 per share.Certara CERT has an Earnings ESP of +5.41% and sports a Zacks Rank #1 at present. You can see the complete list of today’s Zacks #1 Rank stocks here. Certara is set to report its first-quarter ...Drayton Virkler CERT stock SEC Form 4 insiders trading. Drayton has made over 2 trades of the Certara stock since 2022, according to the Form 4 filled with the SEC. Most recently Drayton exercised 3,990 units of CERT stock worth $58,294 on 31 March 2023.. The largest trade Drayton's ever made was exercising 13,595 units of Certara …Conversely, Certara earned 10 cents a share on a non-GAAP basis. Its revenue grew by 14.6% Y/Y to $84.7 million. CERT stock bottomed at $10.60 and closed at $17.72. Certara reiterated its guidance ...How much is Certara stock worth today? ( NASDAQ: CERT) Certara currently has 159,844,780 outstanding shares. With Certara stock trading at $14.64 per share, the total value of Certara stock (market capitalization) is $2.34B. Certara stock was originally listed at a price of $33.59 in Dec 14, 2020.1.90%. $360.63M. Adtran Networks SE. 0.50%. €1.02B. CIEN | Complete Ciena Corp. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

New metrics and analytics capabilities enable informed decision making for biopharmaceutical clientsPRINCETON, N.J., Dec. 13, 2021 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader ...The average twelve-month price prediction for Air Products and Chemicals is $320.31 with a high price target of $360.00 and a low price target of $240.00. Learn more on APD's analyst rating history. Do Wall Street analysts like Air Products and Chemicals more than its competitors?Legal Name Certara, Inc. Stock Symbol NASDAQ:CERT. Company Type For Profit. Contact Email [email protected]. Phone Number 415-237-8272. Certara is a pharmaceutical company that accelerates medicines using biosimulation software and technology to transform traditional drug discovery and development. Its clients include …Instagram:https://instagram. stock trading schools near meroku stocenzc tickersandp 1500 etf PRINCETON, N.J, Oct. 11, 2023 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that it will release financial results for the third quarter of 2023 after the market close on Wednesday November 8th, 2023. Company management will host a conference call to discuss financial results at 5:00PM ET.PRINCETON, N.J.—November 22, 2021– Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the closing of its underwritten public … cme fed funds futuressilver price per ounce forecast The average twelve-month price prediction for Palantir Technologies is $13.25 with a high price target of $25.00 and a low price target of $5.00. Learn more on PLTR's analyst rating history. Do Wall Street analysts like Palantir Technologies more than its competitors? Analysts like Palantir Technologies less than other Business Services … 2009 lincoln cent See the latest Certara Inc Ordinary Shares stock price (CERT:XNAS), related news, valuation, dividends and more to help you make your investing decisions.Certara, Inc. is a provider of biosimulation software and technology-enabled services. The Company is focused on producing medicines for patients using biosimulation software, technology, and services to transform traditional drug discovery and development.